Bentham Science Publishers logo

CNS & Neurological Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal will contain a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in neurological and CNS disorders. As the discovery, identification, characterization and validation of novel human drug targets for neurological and CNS drug discovery continues to grow; this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.

Publisher: Bentham Science Publishers

Volume 1, Number 2, April 2002
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Book Reviews

Preface
pp. i-i(1)
Authors: Tamminga C.A.; Coyle J.T.

Reviews

Current Status of Antipsychotic Treatment
pp. 123-128(6)
Authors: Conley R.R.; Kelly D.L.

Treatment of Schizophrenia and Comorbid Substance Use Disorder
pp. 129-139(11)
Authors: Green A.I.; Salomon M.S.; Brenner M.J.; Rawlins K.

Partial Dopamine Agonists and Dopaminergic Stabilizers, in the Treatment of Psychosis
pp. 141-147(7)
Authors: Tamminga C.A.; Carlsson A.

Nicotinic Agonists and Psychosis
pp. 149-162(14)
Authors: Simosky J.K.; Stevens K.E.; Freedman R.

Muscarinic Receptors as a Target for Drugs Treating Schizophrenia
pp. 163-181(19)
Authors: Bymaster F.P.; Felder C.; Ahmed S.; McKinzie D.

Ionotropic Glutamate Receptors as Therapeutic Targets in Schizophrenia
pp. 183-189(7)
Authors: Coyle J.T.; Tsai G.; Goff D.C.

N-Methyl-D-Aspartate Receptor-Coupled GlycineB Receptors in the Pathogenesis and Treatment of Schizophrenia: A Critical Review
pp. 191-213(23)
Author: Millan M.J.

Preclinical Pharmacology of mGlu2 / 3 Receptor Agonists: Novel Agents for Schizophrenia?
pp. 215-225(11)
Authors: Schoepp D.D.; Marek G.J.

Novel Directions in Antipsychotic Target Identification using Gene Arrays
pp. 227-238(12)
Authors: Palfreyman M.G.; Hook D.J.; Klimczak L.J.; Brockman J.A.; Evans D.M.; Altar C.Anthony

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A